DYRK2 Is Targeted to the Nucleus and Controls p53 via Ser46 Phosphorylation in the Apoptotic Response to DNA Damage

Molecular Cell

Volumn 25, Issue 5, 2007, Pages 725-738

  Taira, Naoe ^a   Nihira, Keishi ^a   Yamaguchi, Tomoko ^a   Miki, Yoshio ^a   Yoshida, Kiyotsugu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

CELLCYCLE; SIGNALING

Indexed keywords

DUAL SPECIFICITY TYROSINE PHOSPHORYLATION REGULATED KINASE 2; PROTEIN KINASE; PROTEIN P53; PROTEIN SERINE KINASE; SERINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL DEATH; CELL FUNCTION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DNA DAMAGE; GENE EXPRESSION; GENOTOXICITY; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; NONHUMAN; PROTEIN PHOSPHORYLATION; TUMOR GENE; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL CYCLE PROTEINS; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; COS CELLS; DNA DAMAGE; DNA-BINDING PROTEINS; GENE LIBRARY; HCT116 CELLS; HELA CELLS; HL-60 CELLS; HUMANS; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 33847350861     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2007.02.007     Document Type: Article

References (45)

1. Abraham R.T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15 (2001) 2177-2196
2. Arron J.R., Winslow M.M., Polleri A., Chang C.P., Wu H., Gao X., Neilson J.R., Chen L., Heit J.J., Kim S.K., et al. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441 (2006) 595-600
3. Becker W., and Joost H.G. Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity. Prog. Nucleic Acid Res. Mol. Biol. 62 (1999) 1-17
4. Becker W., Weber Y., Wetzel K., Eirmbter K., Tejedor F.J., and Joost H.G. Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases. J. Biol. Chem. 273 (1998) 25893-25902
5. Bode A.M., and Dong Z. Post-translational modification of p53 in tumorigenesis. Nat. Rev. Cancer 4 (2004) 793-805
6. Bulavin D.V., Saito S., Hollander M.C., Sakaguchi K., Anderson C.W., Appella E., and Fornace Jr. A.J. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J. 18 (1999) 6845-6854
7. Bulavin D.V., Demidov O.N., Saito S., Kauraniemi P., Phillips C., Amundson S.A., Ambrosino C., Sauter G., Nebreda A.R., Anderson C.W., et al. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat. Genet. 31 (2002) 210-215
8. Campbell L.E., and Proud C.G. Differing substrate specificities of members of the DYRK family of arginine-directed protein kinases. FEBS Lett. 510 (2002) 31-36
9. Chao C., Saito S., Kang J., Anderson C.W., Appella E., and Xu Y. p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage. EMBO J. 19 (2000) 4967-4975
10. D'Orazi G., Cecchinelli B., Bruno T., Manni I., Higashimoto Y., Saito S., Gostissa M., Coen S., Marchetti A., Del Sal G., et al. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat. Cell Biol. 4 (2002) 11-19
11. Finkel T., and Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 408 (2000) 239-247
12. Gwack Y., Sharma S., Nardone J., Tanasa B., Iuga A., Srikanth S., Okamura H., Bolton D., Feske S., Hogan P.G., and Rao A. A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature 441 (2006) 646-650
13. Himpel S., Tegge W., Frank R., Leder S., Joost H.G., and Becker W. Specificity determinants of substrate recognition by the protein kinase DYRK1A. J. Biol. Chem. 275 (2000) 2431-2438
14. Himpel S., Panzer P., Eirmbter K., Czajkowska H., Sayed M., Packman L.C., Blundell T., Kentrup H., Grotzinger J., Joost H.G., and Becker W. Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A. Biochem. J. 359 (2001) 497-505
15. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature 411 (2001) 366-374
16. Hofmann T.G., Moller A., Sirma H., Zentgraf H., Taya Y., Droge W., Will H., and Schmitz M.L. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat. Cell Biol. 4 (2002) 1-10
17. Jimenez G.S., Nister M., Stommel J.M., Beeche M., Barcarse E.A., Zhang X.Q., O'Gorman S., and Wahl G.M. A transactivation-deficient mouse model provides insights into Trp53 regulation and function. Nat. Genet. 26 (2000) 37-43
18. Kentrup H., Becker W., Heukelbach J., Wilmes A., Schurmann A., Huppertz C., Kainulainen H., and Joost H.G. Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII. J. Biol. Chem. 271 (1996) 3488-3495
19. Kim S.T., Lim D.S., Canman C.E., and Kastan M.B. Substrate specificities and identification of putative substrates of ATM kinase family members. J. Biol. Chem. 274 (1999) 37538-37543
20. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
21. Lochhead P.A., Sibbet G., Kinstrie R., Cleghon T., Rylatt M., Morrison D.K., and Cleghon V. dDYRK2: a novel dual-specificity tyrosine-phosphorylation-regulated kinase in Drosophila. Biochem. J. 374 (2003) 381-391
22. Lochhead P.A., Sibbet G., Morrice N., and Cleghon V. Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs. Cell 121 (2005) 925-936
23. Matsuo R., Ochiai W., Nakashima K., and Taga T. A new expression cloning strategy for isolation of substrate-specific kinases by using phosphorylation site-specific antibody. J. Immunol. Methods 247 (2001) 141-151
24. Meek D.W. The p53 response to DNA damage. DNA Repair (Amst.) 3 (2004) 1049-1056
25. Nakamura Y., Futamura M., Kamino H., Yoshida K., Nakamura Y., and Arakawa H. Identification of p53-46F as a super p53 with an enhanced ability to induce p53-dependent apoptosis. Cancer Sci. 97 (2006) 633-641
26. Nishikawa K., Toker A., Johannes F.J., Songyang Z., and Cantley L.C. Determination of the specific substrate sequence motifs of protein kinase C isozymes. J. Biol. Chem. 272 (1997) 952-960
27. Oda K., Arakawa H., Tanaka T., Matsuda K., Tanikawa C., Mori T., Nishimori H., Tamai K., Tokino T., Nakamura Y., and Taya Y. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102 (2000) 849-862
28. Okamura S., Arakawa H., Tanaka T., Nakanishi H., Ng C.C., Taya Y., Monden M., and Nakamura Y. p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol. Cell 8 (2001) 85-94
29. Peltomaki P. DNA mismatch repair and cancer. Mutat. Res. 488 (2001) 77-85
30. Saito S., Goodarzi A.A., Higashimoto Y., Noda Y., Lees-Miller S.P., Appella E., and Anderson C.W. ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation. J. Biol. Chem. 277 (2002) 12491-12494
31. Sancar A., Lindsey-Boltz L.A., Unsal-Kacmaz K., and Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 73 (2004) 39-85
32. Sanchez-Prieto R., Rojas J.M., Taya Y., and Gutkind J.S. A role for the p38 mitogen-activated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents. Cancer Res. 60 (2000) 2464-2472
33. Shiloh Y. ATM and ATR: networking cellular responses to DNA damage. Curr. Opin. Genet. Dev. 11 (2001) 71-77
34. Tatebe H., Shimada K., Uzawa S., Morigasaki S., and Shiozaki K. Wsh3/Tea4 is a novel cell-end factor essential for bipolar distribution of Tea1 and protects cell polarity under environmental stress in S. pombe. Curr. Biol. 15 (2005) 1006-1015
35. Traven A., and Heierhorst J. SQ/TQ cluster domains: concentrated ATM/ATR kinase phosphorylation site regions in DNA-damage-response proteins. Bioessays 27 (2005) 397-407
36. Yin Y., Solomon G., Deng C., and Barrett J.C. Differential regulation of p21 by p53 and Rb in cellular response to oxidative stress. Mol. Carcinog. 24 (1999) 15-24
37. Yoshida K., and Kufe D. Negative regulation of the SHPTP1 protein tyrosine phosphatase by protein kinase C δ in response to DNA damage. Mol. Pharmacol. 60 (2001) 1431-1438
38. Yoshida K., Kharbanda S., and Kufe D. Functional interaction between SHPTP1 and the Lyn tyrosine kinase in the apoptotic response to DNA damage. J. Biol. Chem. 274 (1999) 34663-34668
39. Yoshida K., Weichselbaum R., Kharbanda S., and Kufe D. Role for Lyn tyrosine kinase as a regulator of stress-activated protein kinase activity in response to DNA damage. Mol. Cell. Biol. 20 (2000) 5370-5380
40. Yoshida K., Komatsu K., Wang H.G., and Kufe D. c-Abl tyrosine kinase regulates the human Rad9 checkpoint protein in response to DNA damage. Mol. Cell. Biol. 22 (2002) 3292-3300
41. Yoshida K., Wang H.G., Miki Y., and Kufe D. Protein kinase Cδ is responsible for constitutive and DNA damage-induced phosphorylation of Rad9. EMBO J. 22 (2003) 1431-1441
42. Yoshida K., Yamaguchi T., Natsume T., Kufe D., and Miki Y. JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage. Nat. Cell Biol. 7 (2005) 278-285
43. Yoshida K., Liu H., and Miki Y. Protein kinase C δ regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage. J. Biol. Chem. 281 (2006) 5734-5740
44. Yoshida K., Yamaguchi T., Shinagawa H., Taira N., Nakayama K.I., and Miki Y. Protein kinase C δ activates topoisomerase IIα to induce apoptotic cell death in response to DNA damage. Mol. Cell. Biol. 26 (2006) 3414-3431
45. Zhou B.B., and Elledge S.J. The DNA damage response: putting checkpoints in perspective. Nature 408 (2000) 433-439